Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arch Chemicals, Inc. was a global specialty chemicals company founded in 1998, specializing in biocides for microbial control. Headquartered in Norwalk, CT, it generated approximately $1.4 billion in sales with about 3,000 employees before being acquired by Lonza Group Ltd in 2011 for $1.2 billion. Its products targeted diverse applications including water treatment, wood preservation, paints, personal care, and hygiene, with significant relevance in healthcare-related areas like hospital disinfectants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arch Chemicals.